Sharpely TOS
Trades Own Strategy BrokerTransmit
- hypothetical · Annual Return (Compounded)
- 16.4%
- Max Drawdown
- 20.8%
- Trades
- 401
- Win Trades
- 49.6%
- Profit Factor
- 1.40
- Win Months
- 52.6%
About this strategy
SHARPELY TOS — SYSTEMATIC STOCK ENGINE
Sharpely is a live, TOS-certified systematic stock strategy traded with my own capital through BrokerTransmit.
Historical equity, including pre-C2 performance and current results:
http://tiny.cc/gxf4101
WHY SHARPELY?
Most strategies rely on one market behavior. Sharpely combines multiple independent stock systems within one portfolio designed for long-term compounding.
This is not a passive buy-and-hold portfolio. The strategy blends momentum and mean-reversion systems across different holding periods, all managed within a single portfolio-level risk framework.
The objective is simple:
• capture upside when opportunities are favorable
• reduce exposure when market conditions weaken
• manage risk across the entire portfolio
• compound capital through disciplined execution
Every trade is rule-based. There are no discretionary overrides, no martingale, no averaging down, and no emotional position management.
Position sizing is volatility-aware. Lower-volatility systems can receive more capital, while higher-volatility systems are sized more conservatively.
Exposure can expand when market conditions improve and naturally contract when risk increases.
WHAT MAKES IT DIFFERENT?
• TOS certified and traded with my own capital
• multiple independent equity systems
• fully systematic execution
• dynamic exposure across market regimes
• portfolio-level risk management
• designed to reduce dependence on a single market environment
For the most consistent replication, AutoTrade is recommended and current positions should generally be followed as part of the complete portfolio.
Attack when conditions are favorable.
Step back when risk increases.
Let the process compound.
Sharpely is a live, TOS-certified systematic stock strategy traded with my own capital through BrokerTransmit.
Historical equity, including pre-C2 performance and current results:
http://tiny.cc/gxf4101
WHY SHARPELY?
Most strategies rely on one market behavior. Sharpely combines multiple independent stock systems within one portfolio designed for long-term compounding.
This is not a passive buy-and-hold portfolio. The strategy blends momentum and mean-reversion systems across different holding periods, all managed within a single portfolio-level risk framework.
The objective is simple:
• capture upside when opportunities are favorable
• reduce exposure when market conditions weaken
• manage risk across the entire portfolio
• compound capital through disciplined execution
Every trade is rule-based. There are no discretionary overrides, no martingale, no averaging down, and no emotional position management.
Position sizing is volatility-aware. Lower-volatility systems can receive more capital, while higher-volatility systems are sized more conservatively.
Exposure can expand when market conditions improve and naturally contract when risk increases.
WHAT MAKES IT DIFFERENT?
• TOS certified and traded with my own capital
• multiple independent equity systems
• fully systematic execution
• dynamic exposure across market regimes
• portfolio-level risk management
• designed to reduce dependence on a single market environment
For the most consistent replication, AutoTrade is recommended and current positions should generally be followed as part of the complete portfolio.
Attack when conditions are favorable.
Step back when risk increases.
Let the process compound.
Momentum Short-term Reversal
Hypothetical Monthly Returns (includes fees/commissions)
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | YTD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.3 | -0.4 | -2.8 | -1.8 | -0.8 | 4.1 | 1.4 | 5.6 | 1.8 | 6.6 | |||
| 2026 | 8.9 | 12.9 | 1.3 | 3.6 | 3.8 | 3.9 | -1.1 | -4.5 | -6.7 | -3.4 | 18.3 |
Statistics
Overview
| Strategy began | 4/23/2025 |
|---|---|
| Suggested Minimum Capital | $5,000 |
| Age | 18 months |
| C2 Rank | 317 |
| What it trades | Stocks |
| # Trades | 401 |
| # Profitable | 199 |
| % Profitable | 49.6% |
| Avg trade duration | 22.4 days |
| Max peak-to-valley drawdown | 20.8% |
| drawdown period | July 24, 2026 - Oct 19, 2026 |
| Annual Return (Compounded) | 16.4% |
| Avg win | $164 |
| Avg loss | $121 |
Ratios
| W:L ratio | 1.37 |
|---|---|
| Sharpe Ratio | 0.74 |
| Sortino Ratio | 1.05 |
| Calmar Ratio | 1.31 |
CORRELATION STATISTICS
| Correlation to SP500 | 0.34 |
|---|---|
| Return Percent SP500 (cumu) during strategy life | 43.6% |
| Return of Strat Pcnt - Return of SP500 Pcnt (cumu) | -17.1% |
Return Statistics
| Ann Return (w trading costs) | 16.4% |
|---|---|
| Return Pcnt (Compound or Annual, age-based, NFA compliant) | 0.2% |
| Return Pcnt Since TOS Status | 0.0% |
| Ann Return (Compnd, No Fees) | 22.5% |
Slump
| Current Slump as Pcnt Equity | 20.5% |
|---|---|
| Current Slump, time of slump as pcnt of strategy life | 0.2% |
Instruments
| Percent Trades Forex | 0.0% |
|---|---|
| Percent Trades Futures | 0.0% |
| Percent Trades Options | 0.0% |
| Short Options - Percent Covered | 100.0% |
| Percent Trades Stocks | 1.0% |
Risk of Ruin (Monte-Carlo)
| Chance of 10% account loss | 26.0% |
|---|---|
| Chance of 20% account loss | 5.0% |
| Chance of 30% account loss | 0.0% |
| Chance of 40% account loss | 0.0% |
| Chance of 50% account loss | 0.0% |
| Chance of 60% account loss (Monte Carlo) | 0.0% |
| Chance of 70% account loss (Monte Carlo) | 0.0% |
| Chance of 80% account loss (Monte Carlo) | 0.0% |
| Chance of 90% account loss (Monte Carlo) | 0.0% |
Automation
| Percentage Signals Automated | 0.0% |
|---|
Popularity
| Popularity (Today) | 409 |
|---|---|
| Popularity (Last 6 weeks) | 932 |
| C2 Score | 317 |
| Popularity (7 days, Percentile 1000 scale) | 846 |
Trading Style
| Any stock shorts? 0/1 | 1 |
|---|
Trades-Own-System Certification
| Trades Own System? | 187230 |
|---|---|
| TOS percent | 100.0% |
Win / Loss
| Avg Loss | $121 |
|---|---|
| Avg Win | $164 |
| # Winners | 199 |
| Sum Trade PL (losers) | $24,413 |
| Sum Trade PL (winners) | $32,654 |
| Num Months Winners | 11 |
| # Losers | 202 |
| % Winners | 49.6% |
Dividends
| Dividends Received in Model Acct | 836 |
|---|
Age
| Num Months filled monthly returns table | 19 |
|---|
Frequency
| Avg Position Time (mins) | 32304.98 |
|---|---|
| Avg Position Time (hrs) | 538.42 |
| Avg Trade Length | 22.40 |
| Last Trade Ago | 0 |
Leverage
| Daily leverage (average) | 1.14 |
|---|---|
| Daily leverage (max) | 3.43 |
Regression
| Alpha | 0.01 |
|---|---|
| Beta | 0.47 |
| Treynor Index | 0.09 |
Maximum Adverse Excursion (MAE)
| MAE:Equity, average, all trades | 0 |
|---|---|
| MAE:Equity, 95th Percentile Value for this strat | 0.03 |
| MAE:Equity, average, losing trades | 0.01 |
| MAE:Equity, losing trades only, 95th Percentile Value for this strat | — |
| MAE:Equity, average, winning trades | 0 |
| MAE:Equity, win trades only, 95th Percentile Value for this strat | — |
| Avg(MAE) / Avg(PL) - All trades | 158.93 |
| MAE:PL (avg, all trades) | -0.91 |
| MAE:PL (avg, losing trades) | — |
| MAE:PL (avg, winning trades) | — |
| MAE:PL - worst single value for strategy | — |
| Avg(MAE) / Avg(PL) - Winning trades | 0.56 |
| Avg(MAE) / Avg(PL) - Losing trades | -1.62 |
| Hold-and-Hope Ratio | 0.03 |
RATIO STATISTICS
| Mean | 0.22 |
|---|---|
| SD | 0.15 |
| Sharpe ratio (Glass type estimate) | 1.45 |
| Sharpe ratio (Hedges UMVUE) | 1.38 |
| df | 16 |
| t | 1.73 |
| p | 0.30 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -0.29 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 3.15 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -0.33 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 3.10 |
| Sortino ratio | 3.56 |
| Upside Potential Ratio | 5.19 |
| Upside part of mean | 0.33 |
| Downside part of mean | -0.10 |
| Upside SD | 0.15 |
| Downside SD | 0.06 |
| N nonnegative terms | 10 |
| N negative terms | 7 |
| N of observations | 17 |
| Mean of predictor | 0.24 |
| Mean of criterion | 0.22 |
| SD of predictor | 0.12 |
| SD of criterion | 0.15 |
| Covariance | -0.00 |
| r | -0.13 |
| b (slope, estimate of beta) | -0.17 |
| a (intercept, estimate of alpha) | 0.27 |
| Mean Square Error | 0.03 |
| DF error | 15 |
| t(b) | -0.51 |
| p(b) | 0.58 |
| t(a) | 1.71 |
| p(a) | 0.25 |
| Lowerbound of 95% confidence interval for beta | -0.88 |
| Upperbound of 95% confidence interval for beta | 0.54 |
| Lowerbound of 95% confidence interval for alpha | -0.07 |
| Upperbound of 95% confidence interval for alpha | 0.60 |
| Treynor index (mean / b) | -1.32 |
| Jensen alpha (a) | 0.27 |
| Mean | 0.21 |
| SD | 0.15 |
| Sharpe ratio (Glass type estimate) | 1.40 |
| Sharpe ratio (Hedges UMVUE) | 1.34 |
| df | 16 |
| t | 1.67 |
| p | 0.31 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -0.33 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 3.10 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -0.37 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 3.05 |
| Sortino ratio | 3.28 |
| Upside Potential Ratio | 4.89 |
| Upside part of mean | 0.32 |
| Downside part of mean | -0.10 |
| Upside SD | 0.14 |
| Downside SD | 0.06 |
| N nonnegative terms | 10 |
| N negative terms | 7 |
| N of observations | 17 |
| Mean of predictor | 0.23 |
| Mean of criterion | 0.21 |
| SD of predictor | 0.12 |
| SD of criterion | 0.15 |
| Covariance | -0.00 |
| r | -0.13 |
| b (slope, estimate of beta) | -0.17 |
| a (intercept, estimate of alpha) | 0.25 |
| Mean Square Error | 0.02 |
| DF error | 15 |
| t(b) | -0.50 |
| p(b) | 0.58 |
| t(a) | 1.66 |
| p(a) | 0.26 |
| Lowerbound of 95% confidence interval for beta | -0.88 |
| Upperbound of 95% confidence interval for beta | 0.54 |
| Lowerbound of 95% confidence interval for alpha | -0.07 |
| Upperbound of 95% confidence interval for alpha | 0.57 |
| Treynor index (mean / b) | -1.28 |
| Jensen alpha (a) | 0.25 |
| VaR(95%) | 0.05 |
| Expected Shortfall on VaR | 0.07 |
| VaR(95%) | 0.02 |
| Expected Shortfall on VaR | 0.04 |
| Mean | 0.20 |
| SD | 0.17 |
| Sharpe ratio (Glass type estimate) | 1.21 |
| Sharpe ratio (Hedges UMVUE) | 1.21 |
| df | 378 |
| t | 1.46 |
| p | 0.07 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -0.42 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 2.84 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -0.42 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 2.84 |
| Sortino ratio | 1.79 |
| Upside Potential Ratio | 9.01 |
| Upside part of mean | 1.01 |
| Downside part of mean | -0.81 |
| Upside SD | 0.12 |
| Downside SD | 0.11 |
| N nonnegative terms | 189 |
| N negative terms | 190 |
| N of observations | 379 |
| Mean of predictor | 0.23 |
| Mean of criterion | 0.20 |
| SD of predictor | 0.13 |
| SD of criterion | 0.17 |
| Covariance | 0.01 |
| r | 0.34 |
| b (slope, estimate of beta) | 0.45 |
| a (intercept, estimate of alpha) | 0.10 |
| Mean Square Error | 0.02 |
| DF error | 377 |
| t(b) | 7.06 |
| p(b) | 0 |
| t(a) | 0.75 |
| p(a) | 0.23 |
| Lowerbound of 95% confidence interval for beta | 0.32 |
| Upperbound of 95% confidence interval for beta | 0.57 |
| Lowerbound of 95% confidence interval for alpha | -0.16 |
| Upperbound of 95% confidence interval for alpha | 0.35 |
| Treynor index (mean / b) | 0.44 |
| Jensen alpha (a) | 0.10 |
| Mean | 0.19 |
| SD | 0.17 |
| Sharpe ratio (Glass type estimate) | 1.12 |
| Sharpe ratio (Hedges UMVUE) | 1.12 |
| df | 378 |
| t | 1.35 |
| p | 0.09 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -0.51 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 2.76 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -0.51 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 2.75 |
| Sortino ratio | 1.64 |
| Upside Potential Ratio | 8.79 |
| Upside part of mean | 1.00 |
| Downside part of mean | -0.81 |
| Upside SD | 0.12 |
| Downside SD | 0.11 |
| N nonnegative terms | 189 |
| N negative terms | 190 |
| N of observations | 379 |
| Mean of predictor | 0.22 |
| Mean of criterion | 0.19 |
| SD of predictor | 0.13 |
| SD of criterion | 0.17 |
| Covariance | 0.01 |
| r | 0.34 |
| b (slope, estimate of beta) | 0.45 |
| a (intercept, estimate of alpha) | 0.09 |
| Mean Square Error | 0.02 |
| DF error | 377 |
| t(b) | 7.08 |
| p(b) | 0 |
| t(a) | 0.66 |
| p(a) | 0.25 |
| Lowerbound of 95% confidence interval for beta | 0.33 |
| Upperbound of 95% confidence interval for beta | 0.58 |
| Lowerbound of 95% confidence interval for alpha | -0.17 |
| Upperbound of 95% confidence interval for alpha | 0.34 |
| Treynor index (mean / b) | 0.41 |
| Jensen alpha (a) | 0.09 |
| VaR(95%) | 0.02 |
| Expected Shortfall on VaR | 0.02 |
| VaR(95%) | 0.01 |
| Expected Shortfall on VaR | 0.01 |
| Mean | 0.00 |
| SD | 0.21 |
| Sharpe ratio (Glass type estimate) | 0.00 |
| Sharpe ratio (Hedges UMVUE) | 0.00 |
| df | 130 |
| t | 0.00 |
| p | 0.50 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -2.77 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 2.77 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -2.77 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 2.77 |
| Sortino ratio | 0.00 |
| Upside Potential Ratio | 7.38 |
| Upside part of mean | 1.19 |
| Downside part of mean | -1.19 |
| Upside SD | 0.13 |
| Downside SD | 0.16 |
| N nonnegative terms | 70 |
| N negative terms | 61 |
| N of observations | 131 |
| Mean of predictor | 0.16 |
| Mean of criterion | 0.00 |
| SD of predictor | 0.12 |
| SD of criterion | 0.21 |
| Covariance | 0.01 |
| r | 0.33 |
| b (slope, estimate of beta) | 0.58 |
| a (intercept, estimate of alpha) | -0.10 |
| Mean Square Error | 0.04 |
| DF error | 129 |
| t(b) | 4.02 |
| p(b) | 0.29 |
| t(a) | -0.34 |
| p(a) | 0.52 |
| Lowerbound of 95% confidence interval for beta | 0.30 |
| Upperbound of 95% confidence interval for beta | 0.87 |
| Lowerbound of 95% confidence interval for alpha | -0.65 |
| Upperbound of 95% confidence interval for alpha | 0.46 |
| Treynor index (mean / b) | 0.00 |
| Jensen alpha (a) | -0.10 |
| Mean | -0.02 |
| SD | 0.21 |
| Sharpe ratio (Glass type estimate) | -0.10 |
| Sharpe ratio (Hedges UMVUE) | -0.10 |
| df | 130 |
| t | -0.07 |
| p | 0.50 |
| Lowerbound of 95% confidence interval for Sharpe Ratio | -2.88 |
| Upperbound of 95% confidence interval for Sharpe Ratio | 2.67 |
| Lowerbound of 95% CI (Gibbons, Hedeker & Davis approximation | -2.87 |
| Upperbound of 95% CI (Gibbons, Hedeker & Davis approximation | 2.67 |
| Sortino ratio | -0.13 |
| Upside Potential Ratio | 7.18 |
| Upside part of mean | 1.18 |
| Downside part of mean | -1.20 |
| Upside SD | 0.13 |
| Downside SD | 0.16 |
| N nonnegative terms | 70 |
| N negative terms | 61 |
| N of observations | 131 |
| Mean of predictor | 0.16 |
| Mean of criterion | -0.02 |
| SD of predictor | 0.12 |
| SD of criterion | 0.21 |
| Covariance | 0.01 |
| r | 0.34 |
| b (slope, estimate of beta) | 0.59 |
| a (intercept, estimate of alpha) | -0.11 |
| Mean Square Error | 0.04 |
| DF error | 129 |
| t(b) | 4.05 |
| p(b) | 0.29 |
| t(a) | -0.40 |
| p(a) | 0.52 |
| Lowerbound of 95% confidence interval for beta | 0.30 |
| VAR (95 Confidence Intrvl) | 0.02 |
| Upperbound of 95% confidence interval for beta | 0.88 |
| Lowerbound of 95% confidence interval for alpha | -0.68 |
| Upperbound of 95% confidence interval for alpha | 0.45 |
| Treynor index (mean / b) | -0.04 |
| Jensen alpha (a) | -0.11 |
| VaR(95%) | 0.02 |
| Expected Shortfall on VaR | 0.03 |
| VaR(95%) | 0.01 |
| Expected Shortfall on VaR | 0.02 |
ORDER STATISTICS
| Number of observations | 17 |
|---|---|
| Minimum | 0.94 |
| Quartile 1 | 0.99 |
| Median | 1.02 |
| Quartile 3 | 1.04 |
| Maximum | 1.11 |
| Mean of quarter 1 | 0.97 |
| Mean of quarter 2 | 1.01 |
| Mean of quarter 3 | 1.03 |
| Mean of quarter 4 | 1.08 |
| Inter Quartile Range | 0.05 |
| Number outliers low | 0 |
| Percentage of outliers low | 0 |
| Mean of outliers low | 0 |
| Number of outliers high | 1 |
| Percentage of outliers high | 0.06 |
| Mean of outliers high | 1.11 |
| Extreme Value Index (moments method) | -0.09 |
| VaR(95%) (moments method) | 0.02 |
| Expected Shortfall (moments method) | 0.03 |
| Extreme Value Index (regression method) | 0.27 |
| VaR(95%) (regression method) | 0.03 |
| Expected Shortfall (regression method) | 0.05 |
| Number of observations | 379 |
| Minimum | 0.93 |
| Quartile 1 | 1.00 |
| Median | 1.00 |
| Quartile 3 | 1.01 |
| Maximum | 1.05 |
| Mean of quarter 1 | 0.99 |
| Mean of quarter 2 | 1.00 |
| Mean of quarter 3 | 1.00 |
| Mean of quarter 4 | 1.01 |
| Inter Quartile Range | 0.01 |
| Number outliers low | 8 |
| Percentage of outliers low | 0.02 |
| Mean of outliers low | 0.97 |
| Number of outliers high | 13 |
| Percentage of outliers high | 0.03 |
| Mean of outliers high | 1.03 |
| Extreme Value Index (moments method) | 0.18 |
| VaR(95%) (moments method) | 0.01 |
| Expected Shortfall (moments method) | 0.02 |
| Extreme Value Index (regression method) | 0.25 |
| VaR(95%) (regression method) | 0.01 |
| Expected Shortfall (regression method) | 0.02 |
| Number of observations | 131 |
| Minimum | 0.93 |
| Quartile 1 | 0.99 |
| Median | 1.00 |
| Quartile 3 | 1.01 |
| Maximum | 1.04 |
| Mean of quarter 1 | 0.98 |
| Mean of quarter 2 | 1.00 |
| Mean of quarter 3 | 1.00 |
| Mean of quarter 4 | 1.01 |
| Inter Quartile Range | 0.01 |
| Number outliers low | 3 |
| Percentage of outliers low | 0.02 |
| Mean of outliers low | 0.95 |
| Number of outliers high | 1 |
| Percentage of outliers high | 0.01 |
| Mean of outliers high | 1.04 |
| Extreme Value Index (moments method) | 0.18 |
| VaR(95%) (moments method) | 0.01 |
| Expected Shortfall (moments method) | 0.02 |
| Extreme Value Index (regression method) | 0.29 |
| VaR(95%) (regression method) | 0.02 |
| Expected Shortfall (regression method) | 0.03 |
DRAW DOWN STATISTICS
| Number of observations | 2 |
|---|---|
| Minimum | 0.03 |
| Quartile 1 | 0.05 |
| Median | 0.06 |
| Quartile 3 | 0.08 |
| Maximum | 0.09 |
| Mean of quarter 1 | 0.03 |
| Mean of quarter 2 | 0 |
| Mean of quarter 3 | 0 |
| Mean of quarter 4 | 0.09 |
| Inter Quartile Range | 0.03 |
| Number outliers low | 0 |
| Percentage of outliers low | 0 |
| Mean of outliers low | 0 |
| Number of outliers high | 0 |
| Percentage of outliers high | 0 |
| Mean of outliers high | 0 |
| Extreme Value Index (moments method) | 0 |
| VaR(95%) (moments method) | 0 |
| Expected Shortfall (moments method) | 0 |
| Extreme Value Index (regression method) | 0 |
| VaR(95%) (regression method) | 0 |
| Expected Shortfall (regression method) | 0 |
| Number of observations | 33 |
| Minimum | 0.00 |
| Quartile 1 | 0.00 |
| Median | 0.01 |
| Quartile 3 | 0.03 |
| Maximum | 0.18 |
| Mean of quarter 1 | 0.00 |
| Mean of quarter 2 | 0.01 |
| Mean of quarter 3 | 0.02 |
| Mean of quarter 4 | 0.06 |
| Inter Quartile Range | 0.03 |
| Number outliers low | 0 |
| Percentage of outliers low | 0 |
| Mean of outliers low | 0 |
| Number of outliers high | 1 |
| Percentage of outliers high | 0.03 |
| Mean of outliers high | 0.18 |
| Extreme Value Index (moments method) | 0.35 |
| VaR(95%) (moments method) | 0.07 |
| Expected Shortfall (moments method) | 0.11 |
| Extreme Value Index (regression method) | 0.44 |
| VaR(95%) (regression method) | 0.05 |
| Expected Shortfall (regression method) | 0.09 |
| Number of observations | 15 |
| Minimum | 0.00 |
| Quartile 1 | 0.00 |
| Median | 0.01 |
| Quartile 3 | 0.03 |
| Maximum | 0.18 |
| Mean of quarter 1 | 0.00 |
| Mean of quarter 2 | 0.01 |
| Mean of quarter 3 | 0.02 |
| Mean of quarter 4 | 0.08 |
| Inter Quartile Range | 0.03 |
| Number outliers low | 0 |
| Percentage of outliers low | 0 |
| Mean of outliers low | 0 |
| Number of outliers high | 1 |
| Percentage of outliers high | 0.07 |
| Mean of outliers high | 0.18 |
| Extreme Value Index (moments method) | 0.64 |
| VaR(95%) (moments method) | 0.09 |
| Expected Shortfall (moments method) | 0.26 |
| Extreme Value Index (regression method) | 2.18 |
| VaR(95%) (regression method) | 0.12 |
| Expected Shortfall (regression method) | 0 |
| Strat Max DD how much worse than SP500 max DD during strat life? | -972067840 |
| Max Equity Drawdown (num days) | 87 |
| Last 4 Months - Pcnt Negative | 1.0% |
COMBINED STATISTICS
| Annualized return (arithmetic extrapolation) | 0.28 |
|---|---|
| Compounded annual return (geometric extrapolation) | 0.27 |
| Calmar ratio (compounded annual return / max draw down) | 2.94 |
| Compounded annual return / average of 25% largest draw downs | 2.94 |
| Compounded annual return / Expected Shortfall lognormal | 3.90 |
| j156mfCOMBRisPar | 0 |
| j157mfCOMBRisPar | 0 |
| Annualized return (arithmetic extrapolation) | 0.25 |
| Compounded annual return (geometric extrapolation) | 0.24 |
| Calmar ratio (compounded annual return / max draw down) | 1.31 |
| Compounded annual return / average of 25% largest draw downs | 3.84 |
| Compounded annual return / Expected Shortfall lognormal | 11.83 |
| j313dfCOMBRisPar | 0 |
| j314dfCOMBRisPar | 0 |
| Annualized return (arithmetic extrapolation) | 0.01 |
| Compounded annual return (geometric extrapolation) | 0.01 |
| Calmar ratio (compounded annual return / max draw down) | 0.03 |
| Compounded annual return / average of 25% largest draw downs | 0.08 |
| Compounded annual return / Expected Shortfall lognormal | 0.22 |
Trading record
Placed 784 trades in real-life brokerage accounts.
| Symbol | Side | Qty | Opened | Closed | P/L |
|---|---|---|---|---|---|
| DXCM | long | 11 | Oct 22, 2026 | Oct 29, 2026 | $26 |
| DINO | long | 49 | Oct 28, 2026 | Oct 29, 2026 | $234 |
| MRNA | long | 28 | Oct 23, 2026 | Oct 27, 2026 | $455 |
| CORT | long | 52 | Oct 23, 2026 | Oct 26, 2026 | ($740) |
| PG | long | 24 | Aug 31, 2026 | Oct 22, 2026 | $528 |
| SNA | long | 17 | Sep 28, 2026 | Oct 22, 2026 | ($605) |
| BE | long | 31 | Oct 15, 2026 | Oct 19, 2026 | $272 |
| FORM | long | 56 | Oct 13, 2026 | Oct 19, 2026 | ($642) |
| ALAB | long | 4 | Oct 13, 2026 | Oct 19, 2026 | ($10) |
| CRDO | long | 36 | Oct 13, 2026 | Oct 19, 2026 | ($371) |
| LRCX | long | 9 | Oct 7, 2026 | Oct 19, 2026 | ($437) |
| VICR | long | 34 | Oct 16, 2026 | Oct 19, 2026 | ($17) |
| MRVL | long | 5 | Oct 15, 2026 | Oct 19, 2026 | $51 |
| FLEX | long | 65 | Oct 14, 2026 | Oct 19, 2026 | ($751) |
| VIAV | long | 175 | Oct 13, 2026 | Oct 19, 2026 | ($744) |
| NBIS | long | 13 | Oct 8, 2026 | Oct 19, 2026 | ($627) |
| MCHP | long | 38 | Oct 8, 2026 | Oct 15, 2026 | ($103) |
| BMNR | long | 294 | Oct 8, 2026 | Oct 9, 2026 | $339 |
| RGEN | long | 41 | Oct 7, 2026 | Oct 9, 2026 | $11 |
| BRKR | long | 119 | Oct 7, 2026 | Oct 9, 2026 | $167 |
| TER | long | 7 | Oct 7, 2026 | Oct 9, 2026 | ($22) |
| MPWR | long | 2 | Oct 8, 2026 | Oct 9, 2026 | $40 |
| TEAM | long | 40 | Sep 29, 2026 | Sep 30, 2026 | $466 |
| ALM | long | 424 | Sep 11, 2026 | Sep 15, 2026 | ($161) |
| PATH | long | 912 | Sep 8, 2026 | Sep 9, 2026 | ($182) |
| AXON | long | 12 | Sep 1, 2026 | Sep 3, 2026 | ($247) |
| CRDO | long | 34 | Sep 2, 2026 | Sep 3, 2026 | ($688) |
| AUGO | long | 83 | Aug 31, 2026 | Sep 2, 2026 | $267 |
| P | long | 70 | Aug 28, 2026 | Aug 31, 2026 | $18 |
| ZM | long | 69 | Aug 26, 2026 | Aug 27, 2026 | ($29) |
Past results are not necessarily indicative of future results.
These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.